Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2016 Jul;23(7):2343-9.
doi: 10.1245/s10434-016-5156-9. Epub 2016 Mar 10.

Complications After Percutaneous Pedicle Screw Fixation for the Treatment of Unstable Spinal Metastases

Anne L Versteeg  1 , Jorrit-Jan Verlaan  2 , Paul de Baat  3 , Tim U Jiya  4 , Agnita Stadhouder  4 , Carel H Diekerhof  5 , Guido B van Solinge  6 , F Cumhur Oner  2
Affiliations
Observational Study

Complications After Percutaneous Pedicle Screw Fixation for the Treatment of Unstable Spinal Metastases

Anne L Versteeg et al. Ann Surg Oncol. 2016 Jul.

Abstract

Background: Complications after surgical stabilization for the treatment of unstable spinal metastases are common. Less invasive surgical (LIS) procedures are potentially associated with a lower risk of complications; however, little is known regarding the complications after LIS procedures for the treatment of spinal metastases. Our primary objective was to determine the characteristics and rate of complications after percutaneous pedicle screw fixation (PPSF) for the treatment of mechanically unstable spinal metastases. The secondary objective was to identify factors associated with the occurrence of complications and survival.

Methods: A retrospective multicenter cohort study of patients who underwent PPSF between 2009 and 2014 for the treatment of unstable spinal metastases was performed. Patient data pertaining to demographics, diagnosis, treatment, neurologic function, complications, and survival were collected.

Results: A total of 101 patients were identified, 45 men (45 %) and 56 women (55 %) with a mean age of 60.3 ± 11.2 years. The median operating time was 122 (range 57-325) minutes with a median blood loss of 100 ml (based on 41 subjects). Eighty-eight patients (87 %) ambulated within the first 3 days after surgery. An overall median survival of 11.0 (range 0-70) months was observed, with 79 % of the patients alive at 3 months after treatment. Eighteen patients experienced a total of 30 complications; nonsurgical complications were the most commonly encountered. Prolonged operating time was independently associated with an increased risk of complications.

Conclusions: A complication rate of 18 % was found after PPSF for unstable spinal metastases. Potential advantages of less invasive treatment are limited blood loss and high early ambulation rate.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Kaplan–Meier survival curve. Differences in survival between different tumor types were tested by log-rank test, P < 0.001. Excluding multiple myeloma, P < 0.001
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Nguyen J, Chow E, Zeng L, et al. Palliative response and functional interference outcomes using the Brief Pain Inventory for spinal bony metastases treated with conventional radiotherapy. Clin Oncol. 2011;23:485–491. doi: 10.1016/j.clon.2011.01.507. - DOI - PubMed
    1. Bollen L, van der Linden YM, Pondaag W, et al. Prognostic factors associated with survival in patients with symptomatic spinal bone metastases: a retrospective cohort study of 1043 patients. Neurooncology. 2014;16:991–998. - PMC - PubMed
    1. Falicov A, Fisher CG, Sparkes J, Boyd MC, Wing PC, Dvorak MF. Impact of surgical intervention on quality of life in patients with spinal metastases. Spine. 2006;31:2849–2856. doi: 10.1097/01.brs.0000245838.37817.40. - DOI - PubMed
    1. Gerszten PC, Welch WC. Current surgical management of metastatic spinal disease. Oncology (Williston Park). 2000;14:1013–1036. - PubMed
    1. Lutz S, Berk L, Chang E, et al. Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline. Radiat Oncol Biol. 2011;79:965–976. doi: 10.1016/j.ijrobp.2010.11.026. - DOI - PubMed

Publication types

LinkOut - more resources